Skip to main content
SpringerLink
Log in

Sedative Agents (Benzodiazepines)

  • Chapter
  • First Online:
Sedation and Analgesia for the Pediatric Intensivist

  • 914 Accesses

Abstract

Benzodiazepines are one of the most commonly used sedatives in the pediatric intensive care units for intubation, status epilepticus, and muscle relaxation and now less rarely used for tolerance of mechanical ventilation due to concerns about delirium. This chapter discusses the basic mechanism of action, uses, dosing, and drug interactions of commonly used benzodiazepines in the PICU.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kudchadkar SR, Yaster M, Punjabi NM. Sedation, sleep promotion, and delirium screening practices in the care of mechanically ventilated children: a wake-up call for the pediatric critical care community*. Crit Care Med. 2014;42(7):1592–600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Nutt D. GABAA receptors: subtypes, regional distribution, and function. J Clin Sleep Med. 2006;2(2):S7–11.

    Article  PubMed  Google Scholar 

  3. Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13(2):214–23.

    PubMed  PubMed Central  Google Scholar 

  4. Vet NJ, Kleiber N, Ista E, de Hoog M, de Wildt SN. Sedation in critically ill children with respiratory failure. Front Pediatr. 2016;4:89.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cote CJ, Lerman J, Ward RM, Lugo RA, Goudscouzian N. Pharmacokinetics and pharmacology of drugs used in children. In: A practice of anesthesia for infants and children. 4th ed. Philadelphia: Saunders/Elsevier; 2009. p. 89–146.

    Chapter  Google Scholar 

  6. Malamed S. Pharmacology. In: Sedation: a guide to patient management. 6th ed. St. Louis: Elsevier, Inc; 2018. p. 319–58.

    Google Scholar 

  7. Gorski JC, Hall SD, Jones DR, VandenBranden M, Wrighton SA. Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochem Pharmacol. 1994;47(9):1643–53.

    Article  CAS  PubMed  Google Scholar 

  8. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology–drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157–67.

    Article  CAS  PubMed  Google Scholar 

  9. Blumer JL. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet. 1998;35(1):37–47.

    Article  CAS  PubMed  Google Scholar 

  10. Best KM, Boullata JI, Curley MA. Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model. Pediatr Crit Care Med. 2015;16(2):175–83.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Duceppe MA, Perreault MM, Frenette AJ, et al. Frequency, risk factors and symptomatology of iatrogenic withdrawal from opioids and benzodiazepines in critically ill neonates, children and adults: a systematic review of clinical studies. J Clin Pharm Ther. 2019;44(2):148–56.

    Article  PubMed  Google Scholar 

  12. Pentikainen PJ, Valisalmi L, Himberg JJ, Crevoisier C. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol. 1989;29(3):272–7.

    Article  CAS  PubMed  Google Scholar 

  13. Chicella M, Jansen P, Parthiban A, et al. Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients. Crit Care Med. 2002;30(12):2752–6.

    Article  CAS  PubMed  Google Scholar 

  14. Kraus JW, Desmond PV, Marshall JP, Johnson RF, Schenker S, Wilkinson GR. Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther. 1978;24(4):411–9.

    Article  CAS  PubMed  Google Scholar 

  15. Traube C, Silver G, Reeder RW, et al. Delirium in critically ill children: an international point prevalence study. Crit Care Med. 2017;45(4):584–90.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Traube C, Greenwald BM. “The times they are a-changin”: universal delirium screening in pediatric critical care. Pediatr Crit Care Med. 2017;18(6):594–5.

    Article  PubMed  Google Scholar 

  17. Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000;28(6):2122–32.

    Article  CAS  PubMed  Google Scholar 

  18. Horn E, Nesbit SA. Pharmacology and pharmacokinetics of sedatives and analgesics. Gastrointest Endosc Clin N Am. 2004;14(2):247–68.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Healthcare of Atlanta, Atlanta, GA, USA

    Whitney Moore, Olutola Adu & Sherika Haire-Kendall

Authors
  1. Whitney Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olutola Adu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sherika Haire-Kendall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Whitney Moore , Olutola Adu or Sherika Haire-Kendall .

Editor information

Editors and Affiliations

  1. Associate Professor of Pediatrics, Emory University School of Medicine, Department of Pediatrics, Division of Pediatric Critical Care Medicine, Children’s Healthcare of Atlanta at Egleston, Atlanta, GA, USA

    Pradip P. Kamat

  2. Professor of Pediatrics/Pediatric Critical Care, University of Louisville, “Just For Kids” Critical Care Center, Norton Children’s Hospital, Louisville, KY, USA

    John W. Berkenbosch

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Moore, W., Adu, O., Haire-Kendall, S. (2021). Sedative Agents (Benzodiazepines). In: Kamat, P.P., Berkenbosch, J.W. (eds) Sedation and Analgesia for the Pediatric Intensivist. Springer, Cham. https://doi.org/10.1007/978-3-030-52555-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-52555-2_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-52554-5

  • Online ISBN: 978-3-030-52555-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation